Financial Comparison: Lexaria Bioscience (OTCMKTS:LXRP) versus Lundin Mining (OTC:LUNMF)

Lexaria Bioscience (OTCMKTS:LXRP) and Lundin Mining (OTC:LUNMF) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Earnings and Valuation

This table compares Lexaria Bioscience and Lundin Mining”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lexaria Bioscience	$380,000.00	0.00	-$4.09 million	N/A	N/A
Lundin Mining	$3.42 billion	2.13	$241.56 million	($0.26)	-32.38

Lundin Mining has higher revenue and earnings than Lexaria Bioscience.

Insider and Institutional Ownership

0.1% of Lexaria Bioscience shares are held by institutional investors. Comparatively, 0.1% of Lundin Mining shares are held by institutional investors. 0.4% of Lundin Mining shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Lexaria Bioscience and Lundin Mining, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lexaria Bioscience	0	0	0	0	0.00
Lundin Mining	0	1	0	0	2.00

Given Lexaria Bioscience’s higher possible upside, analysts clearly believe Lexaria Bioscience is more favorable than Lundin Mining.

Profitability

This table compares Lexaria Bioscience and Lundin Mining’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lexaria Bioscience	-1,046.77%	-157.62%	-148.09%
Lundin Mining	-5.15%	5.27%	3.05%

Summary

Lundin Mining beats Lexaria Bioscience on 7 of the 9 factors compared between the two stocks.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.

About Lundin Mining

LUNDIN MINING CORPORATION is a rapidly growing, diversified base metals mining company with operations in Portugal, Spain, Sweden and Ireland. The Company currently has six mines in operation producing copper, nickel, lead and zinc. In addition, Lundin Mining holds a development project pipeline which includes the world class Tenke Fungurume copper cobalt project in the Democratic Republic of Congo and the Ozernoe zinc project in Russia. The Company holds an extensive exploration portfolio and interests in international mining and exploration ventures.